Literature DB >> 18618607

Lung cancer A549 cells migrate directionally in DC electric fields with polarized and activated EGFRs.

Xiaolong Yan1, Jing Han, Zhipei Zhang, Jian Wang, Qingshu Cheng, Kunxiang Gao, Yunfeng Ni, Yunjie Wang.   

Abstract

Endogenous direct-current electric fields (dcEFs) occur in vivo in the form of epithelial transcellular potentials or neuronal field potentials. A variety of cells respond to dcEFs by migrating directionally, and this is termed galvanotaxis. The mechanism by which dcEFs direct cell movement, however, is not yet understood, and the effects on lung cancer cells are entirely unknown. We demonstrated that cultured human lung adenocarcinoma A549 cells migrate toward the cathode in applied dcEFs at 3 V/cm. Fluorescence microscopy showed that both epidermal growth factor receptors (EGFRs) and F-actin are polarized to the cathode. EGFR inhibitors, cetuximab and AG1478, reduced the migration rate and directed motility in dcEFs. Western blots showed that ERK and AKT signaling pathways were prominently promoted by dcEFs. EGFR inhibitors could reduce this promotion but not completely. These data suggest that polarization of EGFRs and the activation of their downstream signals play an important role in the galvanotaxis of A549 cells in dcEFs. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18618607     DOI: 10.1002/bem.20436

Source DB:  PubMed          Journal:  Bioelectromagnetics        ISSN: 0197-8462            Impact factor:   2.010


  28 in total

1.  Electrotaxis of lung cancer cells in ordered three-dimensional scaffolds.

Authors:  Yung-Shin Sun; Shih-Wei Peng; Keng-Hui Lin; Ji-Yen Cheng
Journal:  Biomicrofluidics       Date:  2012-01-04       Impact factor: 2.800

Review 2.  Bioelectric mechanisms in regeneration: Unique aspects and future perspectives.

Authors:  Michael Levin
Journal:  Semin Cell Dev Biol       Date:  2009-05-03       Impact factor: 7.727

3.  In vitro electrical-stimulated wound-healing chip for studying electric field-assisted wound-healing process.

Authors:  Yung-Shin Sun; Shih-Wei Peng; Ji-Yen Cheng
Journal:  Biomicrofluidics       Date:  2012-09-05       Impact factor: 2.800

4.  A novel miniature dynamic microfluidic cell culture platform using electro-osmosis diode pumping.

Authors:  Jen-Yung Chang; Shuo Wang; Jeffrey S Allen; Seong Hyuk Lee; Suk Tai Chang; Young-Ki Choi; Craig Friedrich; Chang Kyoung Choi
Journal:  Biomicrofluidics       Date:  2014-08-11       Impact factor: 2.800

5.  Modulating chemotaxis of lung cancer cells by using electric fields in a microfluidic device.

Authors:  Yu-Chiu Kao; Meng-Hua Hsieh; Chung-Chun Liu; Huei-Jyuan Pan; Wei-Yu Liao; Ji-Yen Cheng; Po-Ling Kuo; Chau-Hwang Lee
Journal:  Biomicrofluidics       Date:  2014-04-01       Impact factor: 2.800

6.  Designing Microfluidic Devices for Studying Cellular Responses Under Single or Coexisting Chemical/Electrical/Shear Stress Stimuli.

Authors:  Tzu-Yuan Chou; Yung-Shin Sun; Hsien-San Hou; Shang-Ying Wu; Yun Zhu; Ji-Yen Cheng; Kai-Yin Lo
Journal:  J Vis Exp       Date:  2016-08-13       Impact factor: 1.355

7.  Electrotaxis of oral squamous cell carcinoma cells in a multiple-electric-field chip with uniform flow field.

Authors:  Hsieh-Fu Tsai; Shih-Wei Peng; Chun-Ying Wu; Hui-Fang Chang; Ji-Yen Cheng
Journal:  Biomicrofluidics       Date:  2012-09-05       Impact factor: 2.800

8.  Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.

Authors:  Brook Chernet; Michael Levin
Journal:  J Clin Exp Oncol       Date:  2013

9.  On the biophysics of cathodal galvanotaxis in rat prostate cancer cells: Poisson-Nernst-Planck equation approach.

Authors:  Przemysław Borys
Journal:  Eur Biophys J       Date:  2012-03-31       Impact factor: 1.733

10.  Translation of the ecological trap concept to glioma therapy: the cancer cell trap concept.

Authors:  Boudewijn van der Sanden; Florence Appaix; François Berger; Laurent Selek; Jean-Paul Issartel; Didier Wion
Journal:  Future Oncol       Date:  2013-06       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.